Continued price increases drove positive results as the company’s organic volume fell 2.5% for the latest quarter.
GLP-1 drug threat “negligible” to PepsiCo, CEO says
Continued price increases drove positive results as the company’s organic volume fell 2.5% for the latest quarter.
Henry Mathieu October 10 2023
